George McAllister
Direttore Tecnico/Scientifico/R&S presso Psynova Neurotech Ltd.
Profilo
George McAllister is currently the Head of Research and Development at Psynova Neurotech Ltd.
Prior to this, he worked as the Director of Molecular and Cellular Neuroscience at Merck & Co., Inc. from 1989 to 2006.
He also worked as the Head of Operations at Oxford BioTherapeutics Ltd.
Posizioni attive di George McAllister
Società | Posizione | Inizio |
---|---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di George McAllister
Società | Posizione | Fine |
---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2006 |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Aziende private | 2 |
---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- George McAllister